However, these findings were not seen in the patients with adenocarcinoma, implying that CHI3L1 risk haplotypes are particularly applicable for predicting the prognosis in patients with SCC, especially in terms of recurrence. This evidence concerns the gene CHI3L1 and adenocarcinoma.